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Abstract
Purpose: Disparities in surgical breast cancer care have been documented for racial and ethnic minorities. On
average, these minorities are less likely to utilize National Cancer Institute (NCI)-designated cancer centers and
travel shorter distances to receive care. With the growing population of Hispanic patients in California, we ana-
lyzed the travel distance and surgical care of Hispanic and non-Hispanic patients at our large referral cancer center.
Methods: Patients included were those who initiated treatment for a new diagnosis of ductal carcinoma in situ
or invasive breast cancer at our NCI-designated cancer center during the period 2010–2014. Ethnicity was dichot-
omized as Hispanic and non-Hispanic. Google Maps were used to determine the distance from patient zip code
to our institution, classified as 0–10, 10–30, 30–60, and >60 miles.
Results: A total of 1765 non-Hispanic and 173 Hispanic patients were identified. Clinical stage by tumor size and
nodal status were comparable between the two groups. Hispanic patients were younger ( p < 0.001) and more
had Medicaid insurance ( p < 0.001). Hispanic patients traveled further when compared with non-Hispanics
( p < 0.001). In non-Hispanics and Hispanics, rates of breast conservation were 57.4% and 52.3% ( p = 0.30), unilat-
eral mastectomy 34.2% and 36.2% ( p = 0.44), bilateral mastectomy 8.4% and 11.5% ( p = 0.24), and immediate
postmastectomy reconstruction 42.6% and 50.6% ( p = 0.34), respectively. Hispanic ethnicity was not associated
with different odds of receiving breast conservation (odds ratio [OR] 1.01, confidence interval [CI] 0.73–1.40), uni-
lateral mastectomy (OR 1.05, CI 0.75–1.44), bilateral mastectomy (OR 1.37, CI 0.81–2.31), or immediate postmas-
tectomy breast reconstruction (OR 1.27, CI 0.86–1.88), when compared with non-Hispanic ethnicity, after
controlling for patient age, insurance status, and distance traveled.
Conclusions: Surgical care was similar for Hispanic and non-Hispanic patients treated at our NCI-designated can-
cer center. However, this Hispanic population traveled further than non-Hispanic patients. Our findings suggest
that accessibility to transportation and institutional practices are instrumental in delivering equitable breast can-
cer surgical care for Hispanic patients.
Keywords: breast cancer; breast reconstruction; health disparities
Introduction
In the United States, racial and ethnic disparities in breast
cancer surgical care have been demonstrated extensively
at the state and nationwide levels.1–3 Investigators have
shown that disparities exist in the receipt of cancer-
directed surgery, breast conservation, breast reconstruc-
tion, and bilateral mastectomy, even after controlling
for the stage of disease.4–9 Specifically, studies have dem-
onstrated lower utilization of breast conservation, contra-
lateral prophylactic mastectomy, and postmastectomy
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breast reconstruction by racial and ethnic minorities.
While patient-related factors such as income,10 insur-
ance,10 primary language,11 and cultural beliefs12 contrib-
ute to differences in receipt of surgical care and surgical
decision-making, recent studies have implicated hospital-
level factors as significant contributors to persistent dis-
parities.13,14
Racial and ethnic minority patients are more likely to
receive care at non-National Cancer Institute (NCI)
centers, low-volume hospitals, and lower resource hos-
pitals.14–17 Furthermore, racial and ethnic minorities
more often receive breast cancer treatments at hospitals
with predominantly minority populations and Medicaid
patients.18 Specifically, Hispanic patients have been
shown to have lower utilization of cancer care at NCI-
designated cancer centers19 or high-volume hospitals.20
Studies have found that greater distance to a hospital
or treatment facility negatively influences the receipt of
postlumpectomy breast radiotherapy as well as postmas-
tectomy breast reconstruction.21–24 On average, white
patients travel further to hospitals than black or His-
panic patients in accessing their healthcare needs.25 Fur-
thermore, prior investigations have shown that black
and Hispanic patients report that travel distance, access
to a car, and availability of a driver limit their potential
to access a hospital.25
The Hispanic population of California is heteroge-
neous and rapidly growing, with an influx of new im-
migrants from South and Central America. Indeed in
2000, Hispanics composed 32.4% of the state’s popula-
tion, which increased to 38.4% by 2013.26 The inci-
dence of breast cancer among Hispanic women is
91.1 per 100,000 population compared with 128.7 for
non-Hispanic whites across the United States.27 An es-
timated 29,360 new cases of breast cancer are expected
in California in 2018 and, based on past estimates of
the California Cancer Registry, *18.4% of these will
occur among Hispanic women. However, these ethnic–
racial distributions are not necessarily replicated in
comprehensive cancer centers.
The aforementioned disparities were the motivat-
ing factor to evaluate the delivery of breast cancer sur-
gical care for Hispanic patients at our institution, a
tertiary NCI-designated cancer center in California.
Moreover, it is possible that the institution’s outreach
in Spanish and efforts to encourage participation in
clinical trials would contribute to equitable delivery
of care. We hypothesized that Hispanics would not
have differences in the receipt of surgical care com-
pared with white patients.
Methods
After obtaining Institutional Review Board approval
from Stanford University, we obtained deidentified
clinical data from the Stanford Cancer Registry Data-
base. Our cohort consisted of female patients who ini-
tiated treatment for ductal carcinoma in situ (DCIS) or
invasive breast cancer at our institution during the
years 2010–2014. Our institution is an NCI-designated
cancer center. The 10 most represented counties for
our cancer center are Santa Clara (30%), San Mateo
(14%), Alameda (11%), San Joaquin (4%), Merced
(4%), Santa Cruz (4%), Contra Costa (3%), Stanislaus
(3%), Monterey (3%), and Solano (1%). The follow-
ing variables were selected and abstracted: age, ethnic-
ity, insurance status, home zip code, tumor size, and
nodal status. Age was categorized as <45, 45–54, 55–
64, 65–74, 75–84, or 85+ years. Patient ethnicity was
categorized as Hispanic or non-Hispanic. Patients
with unknown ethnicity were excluded from the anal-
ysis. All patients included for study had complete de-
mographic and clinical data, and thus the sample size
was equal for all analyses. Distance traveled was calcu-
lated using Google Maps and measured from a central
point of the recorded patient zip code to the address of
our institution, a methodology that has been utilized in
previous studies.28–30 The distance was classified as 0–
10, 10–30, >30–60, and >60 miles. The primary inter-
ventions evaluated were surgical treatments, namely
breast conservation, unilateral mastectomy, bilateral
mastectomy (either for unilateral or bilateral breast
cancer), and immediate postmastectomy breast recon-
struction.
Statistical analyses
Descriptive statistics were performed. Clinical and de-
mographic variables were examined by ethnicity using
the chi-square test and Fisher’s exact test when appro-
priate. The type of surgery and travel distance were ex-
amined by ethnicity using the chi-square test and
Fisher’s exact test when appropriate. Multivariable lo-
gistic regression models were developed to predict the
odds of receiving a specific surgical operation, as a
function of ethnicity. Variables found to be significant
in univariate analysis (patient age, insurance status,
and distance traveled) were included in multivariate
analysis. We performed a subset analysis of patients
who traveled >30 miles so as to specifically query
those patients seeking a tertiary care center distant
from their home. For just those patients who traveled
>30 miles, type of surgery and travel distance were
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examined by ethnicity using the chi-square test and
Fisher’s exact test when appropriate. Multivariable
logistic regression models were developed to predict
the odds of receiving a specific surgical operation, as
a function of ethnicity. Statistical analyses were con-
ducted using Stata, v.5. p-Values <0.05 were consid-
ered statistically significant.
Results
We identified a total of 1677 non-Hispanic patients
(90.5%) and 175 Hispanic patients (9.4%) who received
treatment for newly diagnosed DCIS or invasive breast
cancer over a 5-year period. The distribution of tumor
size and nodal stage did not differ between non-Hispanics
and Hispanics ( p = 0.84 and p = 0.22, respectively,
Table 1). There were more Hispanic patients within
the younger age groups ( p < 0.001) and with Medicaid
insurance ( p < 0.001, Table 1).
Notably, more than one-third (34.3%) of all patients
traveled greater than 60 miles to receive surgical treat-
ment. A significantly higher proportion of Hispanic
women lived further from our cancer center than non-
Hispanic women, with 37.9% of Hispanic women trav-
eling greater than 60 miles to receive surgical care
( p< 0.001, Fig. 1). The largest difference between non-
Hispanic and Hispanic patients was noted in the 30–
60 mile range (9.8% vs. 18.3%, p< 0.001).
In terms of the type of surgery received, there were
no significant differences among these two ethnic
categories (Fig. 2a). Specifically, rates of breast con-
servation were 57.4% and 52.3% ( p = 0.30), unilateral
mastectomy 34.2% and 36.2% ( p = 0.44), and bilateral
mastectomy 8.4% and 11.5% ( p= 0.24) for non-Hispanics
Table 1. Clinical and Demographic Characteristics of Breast
Cancer Patients by Ethnicity
Non-Hispanic, N (%) Hispanic, N (%) p
Clinical T stage
Tis 280 (19.1) 23 (16.2) 0.841
T1 639 (43.5) 64 (45.1)
T2 395 (26.9) 39 (27.5)
T3 121 (8.2) 11 (7.8)
T4 33 (2.3) 5 (3.5)
Clinical N stage
N0 1168 (77.7) 105 (79.7) 0.222
N1 264 (18.0) 32 (22.4)
N2 22 (1.5) 5 (3.5)
N3 11 (0.8) 1 (0.7)
Age, years
< 45 485 (22.1) 63 (34.6) <0.001
45–54 671 (30.5) 56 (30.8)
55–64 474 (21.6) 36 (19.8)
65–74 378 (17.2) 19 (10.4)
75–84 119 (5.4) 7 (3.8)
85+ 72 (3.3) 1 (0.6)
Insurance
Private 1159 (54.1) 76 (41.7) <0.001
Medicaid 213 (9.9) 56 (30.8)
Medicare 474 (22.1) 29 (15.9)
VA/Military 16 (8.42) 3 (1.6)
Uninsured 11 (0.5) 0 (0.0)
Unknown 270 (12.6) 18 (9.9)
Bold indicates clinically significant values of p < 0.05.
FIG. 1. Travel distance to the NCI-designated cancer center significantly differs by patient ethnicity; N Non-
Hispanic = 1765 and N Hispanic = 173. NCI, National Cancer Institute; N, number of patients.
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and Hispanics, respectively. When evaluating immedi-
ate postmastectomy breast reconstruction, we found
that 42.6% of non-Hispanics and 50.6% of Hispanics
underwent reconstruction ( p = 0.34, Fig. 2b).
In multivariate analysis (Table 2), Hispanic ethnicity
was not associated with different odds of receiving
breast conservation (odds ratio [OR] 1.01, confidence
interval [CI] 0.73–1.40), unilateral mastectomy (OR
1.05, CI 0.75–1.44), bilateral mastectomy (OR 1.37,
CI 0.81–2.31), or immediate postmastectomy breast re-
construction (OR 1.27, CI 0.86–1.88), when compared
with non-Hispanic ethnicity, after controlling for patient
age, insurance status, and distance traveled. However,
Medicaid insurance was associated with lower odds of
receiving postmastectomy reconstruction independent
of race (OR 0.61, CI 0.42–0.90, p< 0.05). Increased age
was associated with higher odds of receiving lumpec-
tomy and lower odds of receiving unilateral mastectomy,
bilateral mastectomy, and postmastectomy reconstruc-
tion (Table 2).
When restricting the analysis to patients who trav-
eled more than 30 miles, there were no significant
FIG. 2. (a) No significant differences in receipt of breast cancer-directed surgery by ethnicity; N Non-
Hispanic = 1765 and N Hispanic = 173. All comparisons by ethnicity were not statistically significant. (b) No
significant differences in receipt of postmastectomy breast reconstruction by ethnicity; N Non-Hispanic = 1765
and N Hispanic = 173. All comparisons by ethnicity were not statistically significant.
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differences in the rates of surgical care based on eth-
nicity (Fig. 3a). In non-Hispanics and Hispanics, rates
of breast conservation were 56.0% and 47.0% ( p= 0.30),
unilateral mastectomy 34.8% and 42.0% ( p= 0.44), and
bilateral mastectomy 9.2% and 11.0% ( p = 0.24), re-
spectively. When evaluating immediate postmastectomy
breast reconstruction, we found that 45.7% of non-
Hispanics and 52.8% of Hispanics underwent recon-
struction ( p = 0.34, Fig. 3b).
Discussion
In this 5-year, retrospective single-institution study,
breast cancer surgical care was found to be reassuringly
similar among Hispanic patients compared with non-
Hispanics. However, Hispanics on average traveled fur-
ther to receive care at our institution compared with
non-Hispanics and were more likely to be of young
age and have Medicaid insurance.
Approximately 10% of our patient cohort was His-
panic compared with 12% of all patients cared for in
the Stanford Cancer Institute and compared with
14% of new breast cancer patients in our catchment
area. More than one-third of non-hispanic patients
traveled greater than 60 miles to receive care at our
cancer center, and this number was even higher for
Hispanic patients. This is a surprising finding in
light of other reports. For example, one study of mul-
tiple centers found that less than 2% of patients traveled
>100 km (*60 miles) to receive surgical treatment of
breast cancer.31 Using the National Cancer Database,
Ward et al. described that 8% of all women with
new nonmetastatic breast cancers were treated at a
hospital >50 miles from their home.32 Our results
suggest that our center is unique in its ability to attract
patients from a distance, especially with regard to His-
panic patients. Of note, our cancer center has initiated
several efforts to reach Hispanic patients in the com-
munity and increase their participation in clinical
care and clinical trials at our institution. These efforts
include, but are not limited to, a cancer center webpage
in Spanish, including videos interviewing Hispanic
patients treated at our center, TV and radio advertise-
ments in Spanish, hiring more medical staff who
speak Spanish, providing accessible translation ser-
vices, and hosting an annual educational event to en-
courage participation in clinical trials.
The type of breast cancer operation received among
our Hispanic population did not differ significantly
from non-Hispanics and thus is at odds with other
published reports. Morris et al. found that Hispanic
women in California with early stage breast cancer
had lower odds of receiving breast-conserving sur-
gery.33 Similarly Kurian et al., using the California Can-
cer Registry, found that Hispanic women were more
Table 2. Multivariate Analysis Evaluating the Odds of Receiving Breast Cancer Surgical Care
Breast conservation,
OR (95% CI)
Unilateral mastectomy,
OR (95% CI)
Bilateral mastectomy,
OR (95% CI)
Postmastectomy
reconstruction, OR (95% CI)
Ethnicity
Non-Hispanic Ref Ref Ref Ref
Hispanic 1.01 (0.73–1.40) 1.05 (0.75–1.44) 1.37 (0.81–2.31) 1.27 (0.86–1.88)
Age, years
< 45 Ref Ref Ref Ref
45–54 1.96 (1.55–2.47)** 0.53 (0.42–0.66)** 0.52 (0.37–0.74)** 0.66 (0.51–0.86)*
55–64 2.90 (2.23–3.76)** 0.34 (0.26–0.44)** 0.27 (0.17–0.43)** 0.36 (0.27–0.51)**
65–74 2.68 (1.77–4.07)** 0.37 (0.24–0.55)** 0.10 (0.04–0.24)** 0.15 (0.07–0.29)**
75–84 3.73 (2.13–6.55)** 0.26 (0.15–0.45)* 1.31 (0.86–1.98) 0.06 (0.02–0.20)**
> 85 2.29 (0.63–8.34) 0.27 (0.08–0.86)* n/a n/a
Insurance
Private Ref Ref Ref Ref
Medicaid 0.83 (0.63–1.12) 1.08 (0.82–1.43) 0.60 (0.34–1.05) 0.61 (0.42–0.90)*
Medicare 1.11 (0.75–1.64) 0.91 (0.61–1.33) 2.08 (0.97–4.46) 1.01 (0.55–1.85)
VA/Military 0.96 (0.36–2.60) 0.90 (0.34–2.35) n/a 0.48 (0.11–2.14)
Uninsured 2.30 (0.56–9.50) 0.40 (0.10–1.58) n/a n/a
Distance traveled
< 10 miles Ref Ref Ref Ref
10–29 miles 1.01 (0.79–1.28) 0.97 (0.77–1.24) 0.83 (0.55–1.26) 0.96 (0.71–1.34)
30–59 miles 0.82 (0.58–1.15) 1.18 (0.85–1.64) 0.47 (0.23–0.94)* 1.59 (1.06–2.39)
> 60 miles 0.82 (0.64–1.05) 1.20 (0.94–1.54) 1.31 (0.86–1.98) 1.29 (0.94–1.79)
n/a notes that there were zero patients in this cell.
*p < 0.01, **p< 0.001.
CI, confidence interval; OR, odds ratio.
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likely to receive unilateral mastectomy than breast-
conserving surgery and were less likely to undergo
contralateral prophylactic mastectomy.8 Moreover,
Alderman et al. reported that Hispanic women were
less likely to receive immediate or delayed breast recon-
struction.34 Despite Medicaid expansion, studies show
that lower rates of immediate breast reconstruction per-
sist among Hispanic patients.35
Our findings indicate that differences in surgical care
based on ethnicity can wane in a dedicated tertiary
comprehensive cancer center. This suggests that the
hospital setting influences the level of services deliv-
ered. It is possible that our institution’s efforts to in-
crease Hispanic participation in clinical care at our
hospital were successful and thus could be replicated
in other Hispanic-serving hospitals. On the other
hand, it is possible that Hispanic patients who trav-
eled greater distances were perhaps more educated
about healthcare delivery or simply had the means
of traveling to an institution at a considerable dis-
tance. These findings differ from a report 20 years
ago by Guidry et al. describing that white patients
traveled further to receive breast cancer care than
did black or Hispanic patients.25 In this series, Hispanic
FIG. 3. (a) No significant differences in receipt of breast cancer-directed surgery by ethnicity for patients who
traveled >30 miles; N Non-Hispanic = 780 and N Hispanic = 98. All comparisons by ethnicity were not
statistically significant. (b) No significant differences in receipt of postmastectomy breast reconstruction by
ethnicity for patients who traveled >30 miles; N Non-Hispanic = 780 and N Hispanic = 98. All comparisons by
ethnicity were not statistically significant.
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patients identified distance as a potential barrier to reach
a hospital of choice.
We do not address whether Hispanic patients today
experience fewer barriers to travel, but instead we
focus on the elimination of differences in the quality
of surgical care in a comprehensive cancer center set-
ting. The vast majority of patients with breast cancer
have the option to choose between lumpectomy or
mastectomy as survival is equivalent for invasive can-
cers 4 cm or smaller.36 Neither rates of breast conser-
vation nor tumor size varied by ethnicity at our
institution. Hispanic patients who traveled further
may have visited our center because of referral due
to complexity of cases or lack of reconstructive ser-
vices near their home, distrust of their local hospital,
or as the result of publicity such as the Internet or
TV advertisements that motivated them to travel out-
side a particular geographical area to access a per-
ceived higher level of care.
One of the limitations of this single-institution expe-
rience is that the proportion of newly diagnosed breast
cancer represented by Hispanic patients was only 9.4%,
less than the 18.4% of all new breast cancers that oc-
curred in Hispanic women recorded from 2009 to
2013 in California.37 Furthermore, the approximate in-
cidence of breast cancers among Hispanic women in
the top 3 most represented counties at our cancer cen-
ter during the years of study was 2043,37 with only 173
seen at our center, and thus we can conclude that only a
small proportion of Hispanic patients in our catchment
area did arrive at our center for care and likely repre-
sent a unique population of patients.
While insurance plan designation may restrict ac-
cess to private NCI-designated cancer centers, His-
panic patients treated at our hospital represented
a higher percentage of Medicaid coverage than did
non-Hispanics, suggesting that insurance status may
not have been a limiting factor for those interested in
receiving care at our center. Another limitation of
our dataset is that it was unable to provide information
about patient education level and household income,
which are known to impact surgical breast cancer
care.10 We also did not have a specific home address
for the patients studied, and instead utilized the
home zip code as a proxy, which is somewhat limited
accuracy. Additionally, our analysis did not evaluate
the unknowns of car ownership, utilization of rail ac-
cess or public transit, familial support for travel, or
the practice of seeking second opinions, which all influ-
ence travel distance to a hospital.
Conclusions
Non-Hispanic and Hispanic patients had similar receipt
of breast conservation, unilateral mastectomy, bilateral
mastectomy, and immediate postmastectomy breast re-
construction at our academic NCI cancer center despite
a large body of literature demonstrating ethnic differ-
ences in these domains of treatment. Uniquely, Hispanic
patients traveled further than other patients to receive
care at our hospital, in contradiction to prior reports
of minority patients traveling shorter distances for can-
cer care on average. The capacity of some Hispanic pa-
tients to travel to a hospital of choice is likely related to
complex cultural and socioeconomic factors and would
benefit from further investigation.
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